FR2354778A2 - Vaccins viraux vivants contre la grippe et leur procede de preparation - Google Patents

Vaccins viraux vivants contre la grippe et leur procede de preparation

Info

Publication number
FR2354778A2
FR2354778A2 FR7717898A FR7717898A FR2354778A2 FR 2354778 A2 FR2354778 A2 FR 2354778A2 FR 7717898 A FR7717898 A FR 7717898A FR 7717898 A FR7717898 A FR 7717898A FR 2354778 A2 FR2354778 A2 FR 2354778A2
Authority
FR
France
Prior art keywords
preparation
influenza vaccines
live viral
viral influenza
vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7717898A
Other languages
English (en)
Other versions
FR2354778B2 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Recherche et Industrie Therapeutiques
Original Assignee
Recherche et Industrie Therapeutiques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from BE168041A external-priority patent/BE843094R/fr
Application filed by Recherche et Industrie Therapeutiques filed Critical Recherche et Industrie Therapeutiques
Publication of FR2354778A2 publication Critical patent/FR2354778A2/fr
Application granted granted Critical
Publication of FR2354778B2 publication Critical patent/FR2354778B2/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention est relative aux vaccins vivants contre la grippe Les vaccins de l'invention sont préparés à l'aide d'une souche de virus grippal de type H3 N2 atténuée et résistante aux inhibiteurs sériques. Les vaccins de l'invention sont utilisables dans la prévention de la grippe
FR7717898A 1976-06-18 1977-06-10 Vaccins viraux vivants contre la grippe et leur procede de preparation Granted FR2354778A2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE168041A BE843094R (fr) 1976-06-18 1976-06-18 Vaccins viraux vivants contre la grippe et leur procede de fabrication

Publications (2)

Publication Number Publication Date
FR2354778A2 true FR2354778A2 (fr) 1978-01-13
FR2354778B2 FR2354778B2 (fr) 1980-01-18

Family

ID=3842893

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7717898A Granted FR2354778A2 (fr) 1976-06-18 1977-06-10 Vaccins viraux vivants contre la grippe et leur procede de preparation

Country Status (5)

Country Link
AU (1) AU513734B2 (fr)
CH (1) CH610347A5 (fr)
FR (1) FR2354778A2 (fr)
GB (1) GB1582763A (fr)
NL (1) NL7706710A (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0007467A1 (fr) * 1978-07-12 1980-02-06 Smith Kline - RIT Société anonyme dite: Vaccin antigrippal et procédé pour sa préparation
EP0027249A1 (fr) * 1979-10-16 1981-04-22 Smith Kline - RIT Société anonyme dite: Procédé de préparation de souches vaccinales de virus de l'influenza de type A, souche vaccinale et vaccin la contenant

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0007467A1 (fr) * 1978-07-12 1980-02-06 Smith Kline - RIT Société anonyme dite: Vaccin antigrippal et procédé pour sa préparation
EP0027249A1 (fr) * 1979-10-16 1981-04-22 Smith Kline - RIT Société anonyme dite: Procédé de préparation de souches vaccinales de virus de l'influenza de type A, souche vaccinale et vaccin la contenant

Also Published As

Publication number Publication date
CH610347A5 (en) 1979-04-12
FR2354778B2 (fr) 1980-01-18
AU513734B2 (en) 1980-12-18
GB1582763A (en) 1981-01-14
AU2611577A (en) 1978-12-21
NL7706710A (nl) 1977-12-20

Similar Documents

Publication Publication Date Title
IT8247706A0 (it) Procedimento per la produzione di virus vaccini
NL930132I1 (nl) Vaccin tegen hepatitis B virus werkwijze en getransformeerde eukaryotische cellen en de bereiding van dat vaccin
ES2166361T3 (es) Produccion de plantas resistentes a los virus a traves de la introduccion de rna viral intraducible de sentido positivo.
TNSN88004A1 (fr) Antigenes de surface du virus de l'hepatite b et antigenes hybrides les contenant
DK396381A (da) Faste laegemiddelpraeparater og fremgangsmaade til deres fremstilling
DK169986D0 (da) Antigen beslaegtet med glycoproteinet i aids-virus, isaer en praekursor for glycoproteinet, og fremgangsmaade til fremstilling af et saadant antigen
IL68201A0 (en) Peptides with the specificity of foot and mouth disease viral antigens and compositions and methods for treating animals using the same
ATE47524T1 (de) Hundeparvovirus-impfstoffe.
BE841811A (fr) Vaccin contre l'hepatite b
FR2388564A1 (fr) Nouveau vaccin vivant ameliore contre la pseudopeste aviaire et son procede de preparation
FR2354778A2 (fr) Vaccins viraux vivants contre la grippe et leur procede de preparation
SE7604317L (sv) Fast farmaceutisk doseringsform med fordrojd frigoring och sett att framstella desamma
DK228081A (da) Fremgangsmaade til isolering af virale glycoproteinantigener og dens anvendelse til fremstilling af vacciner
BE872497A (fr) Nouvelles oximes derivees de l'acide 3-substitue 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et les compositions pharmaceutiques les renfermant
BE839306A (fr) Vaccin d'immunisation active contre l'hepatite virale et procede de preparation
DE3853672T2 (de) Nichtzurückschlagende RNS-Viren.
IT1062543B (it) Vaccino contro il virus della rabbia e metodo per la sua preparazione
IT1177147B (it) Composizione farmaceutica per combattere infezioni virali, e procedimento di uso per le infezioni virali
BE827900A (fr) Procede en vue d'immuniser des gorets allaites contre le virus de la gastro-enterite transmissible
FR2443839A1 (fr) Vaccins a base de complexes immuns et leur preparation
FR2620030B1 (fr) Vecteur d'expression des proteines du virus hiv-2, un agent causal du sida, culture cellulaire infectee ou transformee par ce vecteur, proteines obtenues, vaccin et anticorps obtenus
FR2492841B1 (fr) Virus mutant de septicemie hemorragique virale, vaccin contenant ce mutant et procede pour sa preparation
IT8124897A0 (it) Composizione farmaceutica per la terapia di calcolosi renale infetta.
FR2331354A2 (fr) Vaccin d'immunisation active contre l'hepatite virale et procede de preparation
FR2580176B1 (fr) Vaccin antirabique avirulent

Legal Events

Date Code Title Description
CD Change of name or company name